BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30037813)

  • 1. MALDI Mass Spectrometry Imaging Reveals Heterogeneous Distribution of Tenofovir and Tenofovir Diphosphate in Colorectal Tissue of Subjects Receiving a Tenofovir-Containing Enema.
    Seneviratne HK; Hendrix CW; Fuchs EJ; Bumpus NN
    J Pharmacol Exp Ther; 2018 Oct; 367(1):40-48. PubMed ID: 30037813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema.
    Hoang T; Date AA; Ortiz JO; Young TW; Bensouda S; Xiao P; Marzinke M; Rohan L; Fuchs EJ; Hendrix C; Gumber S; Villinger F; Cone RA; Hanes J; Ensign LM
    Eur J Pharm Biopharm; 2019 May; 138():23-29. PubMed ID: 29802984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of tenofovir alafenamide and its active metabolites tenofovir and tenofovir diphosphate in HBV-infected hepatocyte with a sensitive LC-MS/MS method.
    Ouyang B; Zhou F; Zhen L; Peng Y; Sun J; Chen Q; Jin X; Wang G; Zhang J
    J Pharm Biomed Anal; 2017 Nov; 146():147-153. PubMed ID: 28881311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.
    Xiao P; Gumber S; Marzinke MA; Date AA; Hoang T; Hanes J; Ensign LM; Wang L; Rohan L; Fuchs EJ; Hendrix C; Villinger F
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner.
    Lade JM; To EE; Hendrix CW; Bumpus NN
    EBioMedicine; 2015 Sep; 2(9):1145-52. PubMed ID: 26501112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short Communication: Specimen Processing Impacts Tissue Tenofovir Pharmacokinetic Measurements.
    Bakshi RP; Breakey J; Manohar M; Jois B; Fuchs EJ; Marzinke MA
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):354-356. PubMed ID: 29258331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexposure Prophylaxis.
    Nicol MR; Eneh P; Nakalega R; Kaiser T; Kabwigu S; Isingel E; Beksinska M; Sykes C; Fowler MG; Brown TT; Staley C; Kiweewa Matovu F
    Clin Infect Dis; 2020 Apr; 70(8):1717-1724. PubMed ID: 31131846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside Triphosphate Diphosphohydrolase 1 Exhibits Enzymatic Activity toward Tenofovir Diphosphate.
    Seneviratne HK
    Drug Metab Dispos; 2023 Mar; 51(3):385-391. PubMed ID: 36396461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of covariate selection techniques applied to pre-exposure prophylaxis (PrEP) drug concentration data in men and transgender women at risk for HIV.
    Peterson S; Ibrahim M; Anderson PL; Moore CM; MaWhinney S
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):655-669. PubMed ID: 34013454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture.
    Shen Z; Fahey JV; Bodwell JE; Rodriguez-Garcia M; Kashuba AD; Wira CR
    PLoS One; 2014; 9(6):e100863. PubMed ID: 24978212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis.
    Pyra M; Anderson PL; Hendrix CW; Heffron R; Mugwanya K; Haberer JE; Thomas KK; Celum C; Donnell D; Marzinke MA; Bukusi EA; Mugo NR; Asiimwe S; Katabira E; Baeten JM;
    AIDS; 2018 Aug; 32(13):1891-1898. PubMed ID: 29894385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.
    Anderson PL; Liu AY; Castillo-Mancilla JR; Gardner EM; Seifert SM; McHugh C; Wagner T; Campbell K; Morrow M; Ibrahim M; Buchbinder S; Bushman LR; Kiser JJ; MaWhinney S
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa.
    Stranix-Chibanda L; Anderson PL; Kacanek D; Hosek S; Huang S; Nematadzira TG; Taulo F; Korutaro V; Nakabiito C; Masenya M; Lypen K; Brown E; Ibrahim ME; Yager J; Wiesner L; Johnston B; Amico KR; Rooney JF; Chakhtoura N; Spiegel HML; Chi BH;
    Clin Infect Dis; 2021 Oct; 73(7):e1893-e1900. PubMed ID: 33341883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.
    Justman JE; Nair GL; Hendrix CW; Piper JM; Marzinke MA; Dai JY; Pan Z; Galaska B; Levy L; Schwartz JL; Balar B; Kunjara Na Ayudhya RP; Mushamiri I; McGowan I; Dezzutti CS;
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):175-182. PubMed ID: 29767639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal Contraceptives Differentially Suppress TFV and TAF Inhibition of HIV Infection and TFV-DP in Blood and Genital Tract CD4+ T cells.
    Shen Z; Rodriguez-Garcia M; Patel MV; Bodwell J; Kashuba ADM; Wira CR
    Sci Rep; 2017 Dec; 7(1):17697. PubMed ID: 29255206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
    Thurman AR; Schwartz JL; Ravel J; Gajer P; Marzinke MA; Yousefieh N; Anderson SM; Doncel GF
    PLoS One; 2019; 14(5):e0217229. PubMed ID: 31107913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octadecyloxyethyl benzyl tenofovir: A novel tenofovir diester provides sustained intracellular levels of tenofovir diphosphate.
    Beadle JR; Aldern KA; Zhang XQ; Valiaeva N; Hostetler KY; Schooley RT
    Antiviral Res; 2019 Nov; 171():104614. PubMed ID: 31550449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients.
    Kiser JJ; Aquilante CL; Anderson PL; King TM; Carten ML; Fletcher CV
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):298-303. PubMed ID: 18398970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles.
    Cobb DA; Smith N; Deodhar S; Bade AN; Gautam N; Shetty BLD; McMillan J; Alnouti Y; Cohen SM; Gendelman HE; Edagwa B
    Nat Commun; 2021 Sep; 12(1):5458. PubMed ID: 34531390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells.
    Figueroa DB; Madeen EP; Tillotson J; Richardson P; Cottle L; McCauley M; Landovitz RJ; Andrade A; Hendrix CW; Mayer KH; Wilkin T; Gulick RM; Bumpus NN
    AIDS Res Hum Retroviruses; 2018 May; 34(5):421-429. PubMed ID: 29455571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.